Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
24 févr. 2021 10h00 HE
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Global $400+ Million Human Microbiome Therapeutics Market Opportunities and Strategies to 2030
14 janv. 2021 11h03 HE
|
Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
Global Microbiome Therapeutics Markets, 2019-2020 & 2030: Focus on Target Therapies - Gastrointestinal and Infectious Diseases, and Other Diseases
08 janv. 2021 09h18 HE
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Global Microbiome Therapeutics Market: Focus on Target Therapies, Region (10 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030"...
Top 10 Companies in the Global Microbiome Therapeutics Market
29 déc. 2020 04h58 HE
|
Research and Markets
Dublin, Dec. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Microbiome Therapeutics Market 2020: A Benchmark of the Top 10 Companies" report has been added to ResearchAndMarkets.com's offering. This...
Global Microbiome Sequencing Services Market (2020 to 2025) - by Technology, Application, Research Type, Laboratory Type, End-users and Geography
21 déc. 2020 04h53 HE
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market (2020-2025) by Technology, Application, Research Type, Laboratory Type, End-Users, Geography and the...
Global Microbiomes Market Insights & Forecast Report 2020: Market is Forecast to Reach US$9,376 Million in 2024, Growing at a CAGR of 135.47% During 2018-2024
25 nov. 2020 02h58 HE
|
Research and Markets
Dublin, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The "Global Microbiomes Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's...
Global Human Microbiome Market Report 2020-2027 - Growing Technological Advancements in Metagenomics and Next-generation Sequencing
16 nov. 2020 04h43 HE
|
Research and Markets
Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product, Disease, Application, and Geography" report has been added...
$1.3 Billion Microbiome Therapeutics Markets - Global Forecast to 2026
19 oct. 2020 02h28 HE
|
Research and Markets
Dublin, Oct. 19, 2020 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for microbiome therapeutics...
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Psoriasis
06 oct. 2020 09h30 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
Viome launches world’s-first, made to order, precision supplements based on deep health insights
08 sept. 2020 08h00 HE
|
Viome
BELLEVUE, Wash., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Viome, a systems biology company that digitizes, decodes and deciphers human biology with a mission to prevent and reverse chronic diseases, has...